Human oversight is only real if it is designed
Many teams claim “human-in-the-loop” as a control, but in practice it is a person rubber-stamping AI output. In regulated work, oversight must be specific, repeatable, and evidence-producing.
Design the loop with three elements
1) A defined review trigger. Decide what outputs require review: anything affecting a GxP decision, anything with low confidence, and any out-of-distribution input.
2) A review checklist. Reviewers need clear criteria: verify against source records, confirm assumptions, check calculations, confirm references, and assess whether the output is within intended use.
3) A recorded outcome. Capture approve, reject, or revise with rationale. Store it where it can be retrieved during audits.
Make it scalable
Use sampling for low-risk use cases and 100% review for high-risk decision support. Track exceptions and feed them back into prompt improvements and model monitoring.
A good human-in-the-loop control is not “a person looked at it.” It is a defined process that produces auditable evidence.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.